Patient Leaflet Updated 30-Jan-2026 | hameln pharma ltd
Sugammadex 100 mg/ml solution for injection
Sugammadex 100 mg/ml solution for injection
sugammadex
1. What Sugammadex 100 mg/ml solution for injection is and what it is used for
2. What you need to know before Sugammadex 100 mg/ml solution for injection is given
3. How Sugammadex 100 mg/ml solution for injection is given
4. Possible side effects
5. How to store Sugammadex 100 mg/ml solution for injection
6. Contents of the pack and other information
Sugammadex 100 mg/ml solution for injection contains the active substance sugammadex. Sugammadex 100 mg/ml solution for injection is considered to be a Selective Relaxant Binding Agent since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again.
Sugammadex 100 mg/ml solution for injection is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used.
It can be used in newborn babies, infants, toddlers, children and adolescents (birth to 17 years) when rocuronium bromide is used.
Tell your anaesthetist if this applies to you.
Talk to your anaesthetist before Sugammadex 100 mg/ml solution for injection is given
Tell your anaesthetist if you are taking, have recently taken or might take any other medicines.
Sugammadex 100 mg/ml solution for injection may affect other medicines or be affected by them.
It is especially important that you tell your anaesthetist if you have recently taken:
Sugammadex 100 mg/ml solution for injection can make hormonal contraceptives - including the ‘Pill’, vaginal ring, implants or a hormonal IntraUterine System (IUS) - less effective because it reduces how much you get of the progestogen hormone. The amount of progestogen lost by using Sugammadex 100 mg/ml solution for injection is about the same as missing one oral contraceptive Pill.
In general, Sugammadex 100 mg/ml solution for injection does not have an effect on laboratory tests. However, it may affect the results of a blood test for a hormone called progesterone. Talk to your doctor if your progesterone levels need to be tested on the same day you receive Sugammadex 100 mg/ml solution for injection.
Tell your anaesthetist if you are pregnant or might be pregnant or if you are breast-feeding. You may still be given Sugammadex 100 mg/ml solution for injection, but you need to discuss it first.
It is not known whether sugammadex can pass into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding, or whether to abstain from sugammadex therapy, considering the benefit of breast-feeding to the baby and the benefit of Sugammadex 100 mg/ml solution for injection to the mother.
Sugammadex 100 mg/ml solution for injection has no known influence on your ability to drive and use machines.
This medicine contains up to 9.7 mg sodium (main component of cooking/table salt) in each millilitre.
This is equivalent to 0.5 % of the recommended maximum daily dietary intake of sodium for an adult.
Sugammadex 100 mg/ml solution for injection will be given to you by your anaesthetist, or under the care of your anaesthetist.
Your anaesthetist will work out the dose of Sugammadex 100 mg/ml solution for injection you need based on:
The usual dose is 2-4 mg per kg body weight for adults and for patients of any age. A dose of 16 mg/kg can be used in adults if urgent recovery from muscle relaxation is needed.
Sugammadex 100 mg/ml solution for injection will be given to you by your anaesthetist. It is given as a single injection through an intravenous line.
As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Sugammadex 100 mg/ml solution for injection. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anaesthetist or other doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If these side effects occur while you are under anaesthesia, they will be seen and treated by your anaesthetist.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Frequency not known
If you get any side effects, talk to your anaesthetist or other doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Storage will be handled by healthcare professionals.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and on the label after ‘EXP’. The expiry date refers to the last day of that month.
Keep the vial in the outer carton in order to protect from light.
This medicine does not require any special temperature storage conditions.
After first opening and dilution, store at 2 to 8°C and use within 24 hours.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Sugammadex 100 mg/ml solution for injection is a clear, colourless to slightly yellow brown solution for injection, practically free from particles.
It comes in two different pack sizes, containing either 5 or 10 vials with 2 ml or 5 or 10 vials with 5 ml solution for injection.
Not all pack sizes may be marketed.
Marketing Authorisation Holder:
Manufacturer(s):
This medicinal product is authorised in the Member States of the EEA under the following names:
The Netherlands Sugammadex hameln 100 mg/ml oplossing voor injectie
Austria Sugammadex-hameln 100 mg/ml Injektionslösung
Germany Sugammadex-hameln 100 mg/ml Injektionslösung
Denmark Sugammadex hameln
Finland Sugammadex hameln 100 mg/ml injektioneste, liuos
Norway Sugammadex hameln
This leaflet was last revised in 08/2025.
xxxx/37/25
Nexus, Gloucester Business Park, Gloucester, GL3 4AG, UK
+44 (0)1452 621 661
https://www.hameln-pharma.com
+44 (0)1452 632 732